Know Cancer

forgot password

Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness

18 Years
30 Years
Open (Enrolling)
Mental Illness, Tobacco Smoking, Young Adults

Thank you

Trial Information

Decision Support for Smoking Cessation in Young Adults With Severe Mental Illness

The research will take place over 2 years at the Long Island Zucker Hillside Hospital
system. In Year 1, we will adapt our electronic decision support system, a web-based
motivational tool, for young smokers with severe mental illness. We will first identify
beliefs of young smokers with severe mental illness that impede use of smoking cessation
treatments. Then, the decision support system will be revised to change these beliefs,
field-tested for usability, and improved as needed. In Year 2, we will conduct a randomized
control trial of the newly revised version of the system among 60 young smokers with severe
psychotic disorders.

In the controlled trial, participants will be assessed at baseline for mental health
symptoms and smoking behavior and history, and then randomized to use the system or a
computerized public health pamphlet (control condition) within two weeks. Participants will
be assessed again at 14-week follow-up for clinician-confirmed initiation of smoking
cessation treatment (main outcome), beliefs, and smoking characteristics. Analyses will
assess whether use of the decision support system results in greater initiation of cessation
treatment (main outcome), and changes in beliefs about treatment, than use of the control

Inclusion Criteria:

English-speaking; non-pregnant/nursing; daily smokers; age 18-30; psychiatrically stable;
in treatment in the Zucker Hillside Hospital system; diagnosed with SMI (schizophrenia,
schizoaffective disorder, or mood disorder with psychotic features from medical chart);
willing and able to give informed consent.

Exclusion Criteria:

(Phase 4 only): current (within the past month) use of evidence-based smoking cessation
treatment (indicating the subject is already motivated), psychiatric instability (Modified
Colorado Symptom Index score >45), current untreated substance use disorder (SUD)

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Outcome Measure:

Change in Smoking Cessation Treatment measured by the behavioral Checklist delivered at baseline and 14 weeks

Outcome Description:

Assesses through self-report and clinician confirmation any engagement in behavioral smoking cessation treatment and/or smoking cessation medication treatment.

Outcome Time Frame:

Baseline and 14 weeks

Safety Issue:


Principal Investigator

Mary F. Brunette, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Dartmouth-Hitchcock Medical Center


United States: Federal Government

Study ID:

R21 CA158863-01A1



Start Date:

January 2013

Completion Date:

March 2015

Related Keywords:

  • Mental Illness
  • Tobacco Smoking
  • Young Adults
  • Mental Illness
  • Tobacco Smoking
  • Young Adults
  • Treatment Engagement
  • Motivational Intervention
  • Mental Disorders
  • Smoking



Zucker-Hillside HospitalGlen Oaks, New York  11004